Pharmacokinetic analysis of 6-monoamino-β-cyclodextrin after intravenous oral administration to rats using a specific enzyme immunoassay

Journal of Pharmaceutical Sciences

Volumn 88, Issue 3, 1999, Pages 302-305

  Créminon, Christophe ^a   Djedaïni Pilard, Florence ^a   Vienet, Raymond ^a   Péan, Christophe ^a   Grognet, Jean Marc ^a   Grassi, Jacques ^a   Perly, Bruno ^a   Pradelles, Philippe ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; POLYCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STABILITY; ENZYME IMMUNOASSAY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA CLEARANCE; RAT;

EID: 0141646855     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9802998     Document Type: Article

References (27)

1. Loftsson, T.; Brewster, M. Pharmaceutical applications. 1. Drug solubilization and stabilization. J. Pharm. Sci. 1996, 85, 1017-1025.
2. Stella, V.; Rajewski, R. Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 1997, 14, 556-567.
3. Schipper, N.; Verhoef, J.; De Lannoy, L.; Romeijn, S.; Brakkee, J.; Wiegant, V.; Gispen, W.; Merkus F. Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics. Br. J. Pharmacol. 1993, 110, 1335-1340.
4. Zhao, Q.; Temsamani, J.; Agrawal, S. Use of cyclodextrin and its derivatives as carrier for oligonucleotide delivery. Antisense Res. Rev. 1995, 5, 185-192.
5. Zhao, Q.; Temsamani, J.; Iadarola, P.; Agrawal, S. Modulation of oligonucleotide-induced immune stimulation by cyclodextrin analogues. Biochem. Pharmacol. 1996, 52, 1537-1544.
6. Frank, D.; Gray, J.; Weaver, R. Cyclodextrin nephrosis in the rat. Am. J. Pathol. 1976, 83, 367-382.
7. Shiotani, K.; Uehata, K.; Irie, T.; Uekama, K.; Thompson, D.; Stella, V. Differential effects of sulfate and sulfobutyl ether of beta-cyclodextrin on erythrocyte membranes in vitro. Pharm. Res. 1995, 12, 78-84.
8. Irie, T.; Uekama, K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 1997, 86, 147-162.
9. Bost, M.; Lainé, V.; Pilard, P.; Gadelle, A.; Defaye, J.; Perly, B. The hemolytic properties of chemically modified cyclodextrins. J. Inclus. Phenom. Mol. Recogn. 1997, 29, 57-63.
10. Petter, R.; Salek, J.; Sikorski, C.; Kumaravel, G.; Lin, F. Cooperative binding by aggregated mono-6-(alkylamino)-β-cyclodextrins. J. Am. Chem. Soc. 1990, 112, 3860-3868.
11. Takahashi, K.; Hattori, K.; Toda, F. Monotosylated α and β-cyclodextrins prepared in an alkaline aqueous solution. Tetrahedron Lett. 1984, 25, 3331-3334.
12. Djedaïni-Pilard, F.; Desalos, J.; Perly, B. Synthesis of a new molecular carrier: N(Leu-enkephalin)yl-6-amido-6-deoxycyclomaltoheptaose. Tetrahedron Lett. 1993a, 34, 2457-2460.
13. Djedaïni-Pilard, F.; Perly, B. Utilisation de cyclodextrines aminées pour la solubilisation aqueuse de composés hydrophobes, en particulier de molécules pharmaceutiquement actives. French Patent 93-15472, 1993b.
14. Djedaïni-Pilard, F.; Azaroual-Bellanger, N.; Gosnat, M.; Vernet, D.; Perly, B. Potential formation of intramolecular inclusion complexes in peptido-cyclodextrins as evidenced by NMR spectroscopy. J. Chem. Soc., Perkin Trans. 2 1995, 723-730.
15. Massoulié, J.; Bon, S. Affinity chromatography of acetylcholinesterase: the importance of hydrophobic interactions. Eur. J. biochem. 1976, 68, 531-539.
16. Ellman, G.; Courtney, K.; Andres, V.; Featherstone, R. A new and rapid colorimetric determination of acetylcholine esterase activity. Biochem. Pharmacol. 1961, 7, 88-95.
17. Créminon, C.; Pilard, F.; Grassi, J.; Perly, B.; Pradelles, P. A sensitive and specific enzyme immunoassay for cyclomaltoheptaose and some derivatives. Carbohydr. Res. 1994, 258, 179-186.
18. McLaughlin, L.; Wei, Y.; Stockman, P.; Leahy, K.; Needleman, P.; Grassi, J.; Pradelles, P. Development, validation and application of an enzyme immunoassay (EIA) of atriopeptin. Biochem. Biophys. Res. Commun. 1987, 144, 469-476.
19. Pradelles, P.; Grassi, J.; Chabardes, D.; Guiso, N. Enzyme immunoassays of adenosine cyclic 3′,5′-monophosphate and guanosine cyclic 3′,5′-monophosphate using acetylcholinesterase. Anal. Chem. 1989, 61, 447-453.
20. Grassi, J.; Frobert, Y.; Pradelles, P.; Chercuitte, D.; Gruaz, D.; Dayer, J.-M.; Pradelles, P. Production of monoclonal antibodies against interleukin-1α and -1β; Development of two enzyme immunoassays (EIA) using acetylcholinesterase and their application to biological media. J. Immunol. Methods 1989, 123, 193-210.
21. Rodnard, D.; Lewald, J. Computer analysis of radioligand assay and radioimmunoassay data. Acta Endocrinol. 1970, 64, 79-103.
22. Gibaldi, M.; Perrier, D. In Pharmacokinetics in drugs and the pharmaceutical sciences; Marcel Dekker: New York, 1982; pp 15-48.
23. Bivin, W.; Crawford, M.; Brewer, N. In The laboratory rat: biology and diseases; Barker, H., Lindsey, J., Weisbroth, S., Eds; Academic Press: New York, 1979; Vol. 1, pp 90-95.
24. Frijlink, H.; Visser, J.; Hefting, N.; Oosting, R.; Meijer, D.; Lerk, C. The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in rat. Pharm. Res. 1990, 7, 1248-1252.
25. Gerloczi, A.; Fonagy, A.; Keresztes, P.; Perlaky, L.; Szejtli, J. Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat. Arzneim. Forsch. 1985, 35, 1042-1047.
26. Kubota, Y., Fukuda, M.; Muroguchi, M.; Koizumi, K. Absorption, distribution and excretion of beta-cyclodextrin and glucosyl-beta-cyclodextrin in rats. Biol. Pharm. Bull. 1996, 19, 1068-1072.
27. Kubota, Y., Fukuda, M.; Ohtsuji, K.; Koizumi, K. Microanalysis of beta-cyclodextrin and glucosyl-beta-cyclodextrin in human plasma by high-performance liquid chromatography with pulsed amperometric detection. Anal. Biochem. 1992, 201, 99-102.